[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336154-105":59,"doc-detail-336154-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integration-of-single-cell-rna-seq-and-bulk-rna-seq-to-construct-liver-hepatocellular-carcinoma-stem-cell-signatures-to-explore-their-impact-on-patient-prognosis-and-treatment","Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment","","Liver hepatocellular carcinoma (LIHC) is a common primary liver cancer, and evidence links tumor stem cells to recurrence, metastasis, and resistance to therapy. However, established cancer stem cell–associated gene signatures for prognosis prediction and treatment guidance in LIHC remain limited. Using public single-cell and bulk RNA datasets, the study quantifies stemness, links stemness indicators with clinical and survival outcomes, builds a prognostic model, evaluates immune infiltration, and estimates immunotherapeutic response to support clinical decision-making.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integration-of-single-cell-rna-seq-and-bulk-rna-seq-to-construct-liver-hepatocellular-carcinoma-stem-cell-signatures-to-explore-their-impact-on-patient-prognosis-and-treatment/336154/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integration-of-single-cell-rna-seq-and-bulk-rna-seq-to-construct-liver-hepatocellular-carcinoma-stem-cell-signatures-to-explore-their-impact-on-patient-prognosis-and-treatment/336154.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data types were integrated to evaluate stemness in LIHC?","Question",{"text":112,"@type":113},"The study integrated single-cell RNA-seq and bulk RNA transcriptome data from public datasets. Stemness was assessed using CytoTRACE and an OCLR-based approach to estimate stemness level and mRNAsi.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were stemness indicators connected to prognosis and clinical features?",{"text":117,"@type":113},"The CytoTRACE score and mRNAsi were associated with survival outcomes and clinical characteristics using clinical information and survival analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What methods were used to derive prognostic genes and immune-related assessments?",{"text":121,"@type":113},"Weighted co-expression network analysis and Cox modeling were used to identify mRNAsi-related genes and construct a prognostic model. Immune infiltration was evaluated with ssGSEA, CIBERSORT, and TIMER, and immunotherapeutic response was predicted using TIDE.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336154,1790196987,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","PLOS ONE  \nOPEN ACCESS  \nCitation: Liu L, Zhang M, Cui N, Liu W, Di G, Wang Y, et al. (2024) Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment. PLoSONE 19(4): e0298004 . [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0298004](journal.pone.0298004)  \nEditor: Yuanliang Yan, Xiangya Hospital Central South University, CHINA  \nReceived: November 13, 2023  \nAccepted: January 11, 2024  \nPublished: April 18, 2024  \nCopyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: The dataset analyzed in this study is available in [GSE149614] at [[https://](https://)[ ](https://)[www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=](www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=)[ ](www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=)[GSE149614](GSE149614)].  \nFunding: This study was supported by Medical Science Foundation of Hebei University (2020B08), Government Foundation of Clinical Medicine Talents Training Program of Hebei Province (ZF2024213), and Medical Science Foundation of Hebei University (2023A04) .  \nRESEARCH ARTICLE  \nIntegration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment  \nLixia Liu1☯, Meng Zhang2☯, Naipeng Cui3, Wenwen Liu3, Guixin Di4, Yanan Wang5, Xin Xi6, Hao Li6, Zhou Shen6, Miaomiao Gu4, Zichao Wang4, Shan Jiang6, Bin Liu6 *  \n1 Department of Ultrasound and Hebei Key Laboratory of Precise Imaging of Inflammation Related Tumors, Affiliated Hospital of Hebei University, Baoding, 071052, China, 2 Department of Hepatobiliary Surgery, Affiliated Hospital of Hebei University, Baoding, 071052, China, 3 Department of Breast Surgery, Affiliated Hospital of Hebei University, Baoding, 071052, China, 4 Department of Ultrasound, Affiliated Hospital of Hebei University, Baoding, 071052, China, 5 Department of Pathology, Affiliated Hospital of Hebei University, Baoding, 071052, China, 6 Central Laboratory, Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Affiliated Hospital of Hebei University, Baoding, 071052, China  \n☯ These authors contributed equally to this work.  \n* [liubinhbu@hbu.edu.cn](liubinhbu@hbu.edu.cn)  \nAbstract  \nBackground  \nLiver hepatocellular carcinoma (LIHC) is a prevalent form of primary liver cancer. Research has demonstrated the contribution of tumor stem cells in facilitating tumor recurrence, metastasis, and treatment resistance. Despite this, there remains a lack of established cancer stem cells (CSCs)-associated genes signatures for effectively predicting the prognosis and guiding the treatment strategies for patients diagnosed with LIHC.  \nMethods  \nThe single-cell RNA sequencing (scRNA-seq) and bulk RNA transcriptome data were obtained based on public datasets and computerized firstly using CytoTRACE package and One Class Linear Regression (OCLR) algorithm to evaluate stemness level, respectively. Then, we explored the association of stemness indicators (CytoTRACE score and stemness index, mRNAsi) with survival outcomes and clinical characteristics by combining clinical information and survival analyses. Subsequently, weighted co-expression network analysis (WGCNA) and Cox were applied to assess mRNAsi-related genes in bulk LIHC data and construct a prognostic model for LIHC patients. Single-sample gene-set enrichment analysis (ssGSEA), Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORT) and Tumor Immune Estimation Resource (TIMER) analysis were employed for immune infiltration assessment. Finally, the potential immunotherapeutic response was predicted by t","cbCaiutpqzfMmE1S","https://ap.wps.com/l/cbCaiutpqzfMmE1S","pdf",4580077,"English","# Abstract\n## Background\n## Methods\n## Results","[{\"question\":\"What data types were integrated to evaluate stemness in LIHC?\",\"answer\":\"The study integrated single-cell RNA-seq and bulk RNA transcriptome data from public datasets. Stemness was assessed using CytoTRACE and an OCLR-based approach to estimate stemness level and mRNAsi.\"},{\"question\":\"How were stemness indicators connected to prognosis and clinical features?\",\"answer\":\"The CytoTRACE score and mRNAsi were associated with survival outcomes and clinical characteristics using clinical information and survival analyses.\"},{\"question\":\"What methods were used to derive prognostic genes and immune-related assessments?\",\"answer\":\"Weighted co-expression network analysis and Cox modeling were used to identify mRNAsi-related genes and construct a prognostic model. Immune infiltration was evaluated with ssGSEA, CIBERSORT, and TIMER, and immunotherapeutic response was predicted using TIDE.\"}]","Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment | PDF",1790013897,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af34d3c5db7b15a1715477ea686f4085.webp",983,1272,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce199ca5d85d2b144259a86487486155.webp",982,1270,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b13d7104a15a17cd27b6a295b873ebb.webp",981,1269,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb197cd1948b70fe0ce7189faed99b0d.webp",980,1268]